FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064742811> ?p ?o ?g. }

• W2064742811 endingPage "348" @default.
• W2064742811 startingPage "339" @default.
• W2064742811 abstract "Selection of first-line antiretroviral therapy requires consideration of efficacy as well as effects on lipids given the increased concern about cardiovascular risk in HIV-1 patients.ARTEN is a randomized, open-label, non-inferiority trial that compares nevirapine (NVP) 200 mg twice daily or 400 mg once daily to atazanavir/ritonavir (ATZ/r) 300 mg/100 mg once daily, each combined with fixed-dose tenofovir disoproxil fumarate (TDF) 300 mg/emtricitabine (FTC) 200 mg once daily, in antiretroviral-naive HIV-1 patients with CD4(+) T-cell counts <400 (men) and <250 cells/mm(3) (women). The primary end point was plasma HIV RNA<50 copies/ml at two consecutive visits prior to week 48.A total of 569 patients were randomized and treated. Overall, 66.8% of NVP and 65.3% of ATZ/r patients achieved the primary end point (difference 1.9%, 95% CI -5.9-9.8%). Similar rates of serious adverse events were observed (9.6% on NVP versus 8.8% on ATZ/r), although discontinuations due to adverse events were more frequent with NVP than ATZ/r (13.6% versus 3.6%, respectively). None of the 28 patients virologically failing ATZ/r selected resistance mutations, while they were selected in 29/44 patients virologically failing NVP. NVP induced a significantly greater increase in high-density lipoprotein cholesterol (HDL-c) and apolipoprotein A1 from baseline than ATZ/r, whereas triglycerides increased significantly more with ATZ/r than NVP. Mean change from baseline in TC:HDL-c ratio was -0.24 for NVP and 0.13 for ATZ/r (P=0.0001).NVP demonstrated at week 48 non-inferior antiviral efficacy compared with ATZ/r when given along with TDF/FTC, despite more drug-related discontinuations with NVP than ATZ/r. NVP was associated with a lower atherogenic lipid profile than ATZ/r although resistance mutations were more frequently selected with NVP than ATZ/r." @default.
• W2064742811 created "2016-06-24" @default.
• W2064742811 creator A5009751300 @default.
• W2064742811 creator A5012384912 @default.
• W2064742811 creator A5014137251 @default.
• W2064742811 creator A5021206943 @default.
• W2064742811 creator A5024752023 @default.
• W2064742811 creator A5027093678 @default.
• W2064742811 creator A5027440713 @default.
• W2064742811 creator A5041319608 @default.
• W2064742811 creator A5059386443 @default.
• W2064742811 creator A5067134665 @default.
• W2064742811 creator A5072216201 @default.
• W2064742811 creator A5072944678 @default.
• W2064742811 creator A5077428594 @default.
• W2064742811 date "2010-04-01" @default.
• W2064742811 modified "2023-10-16" @default.
• W2064742811 title "Nevirapine versus Atazanavir/Ritonavir, Each Combined with Tenofovir Disoproxil Fumarate/Emtricitabine, in Antiretroviral-Naive HIV-1 Patients: The Arten Trial" @default.
• W2064742811 cites W1520954009 @default.
• W2064742811 cites W17286363 @default.
• W2064742811 cites W1767400858 @default.
• W2064742811 cites W1967326599 @default.
• W2064742811 cites W1983329444 @default.
• W2064742811 cites W1997321745 @default.
• W2064742811 cites W2009282612 @default.
• W2064742811 cites W2017880703 @default.
• W2064742811 cites W2027755499 @default.
• W2064742811 cites W2032130021 @default.
• W2064742811 cites W2054989011 @default.
• W2064742811 cites W2057389182 @default.
• W2064742811 cites W2057394385 @default.
• W2064742811 cites W2066267771 @default.
• W2064742811 cites W2074725040 @default.
• W2064742811 cites W2076420181 @default.
• W2064742811 cites W2085088518 @default.
• W2064742811 cites W2110559078 @default.
• W2064742811 cites W2114793603 @default.
• W2064742811 cites W2117261241 @default.
• W2064742811 cites W2121435314 @default.
• W2064742811 cites W2130123919 @default.
• W2064742811 cites W2130575607 @default.
• W2064742811 cites W2133945773 @default.
• W2064742811 cites W2137230427 @default.
• W2064742811 cites W2141776019 @default.
• W2064742811 cites W2147357250 @default.
• W2064742811 cites W2163111234 @default.
• W2064742811 cites W2165762745 @default.
• W2064742811 cites W2167865974 @default.
• W2064742811 cites W2168784348 @default.
• W2064742811 cites W2171236519 @default.
• W2064742811 cites W4240153861 @default.
• W2064742811 cites W54976040 @default.
• W2064742811 cites W1966665909 @default.
• W2064742811 doi "https://doi.org/10.3851/imp1745" @default.
• W2064742811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21555816" @default.
• W2064742811 hasPublicationYear "2010" @default.
• W2064742811 type Work @default.
• W2064742811 sameAs 2064742811 @default.
• W2064742811 citedByCount "95" @default.
• W2064742811 countsByYear W20647428112012 @default.
• W2064742811 countsByYear W20647428112013 @default.
• W2064742811 countsByYear W20647428112014 @default.
• W2064742811 countsByYear W20647428112015 @default.
• W2064742811 countsByYear W20647428112016 @default.
• W2064742811 countsByYear W20647428112017 @default.
• W2064742811 countsByYear W20647428112018 @default.
• W2064742811 countsByYear W20647428112019 @default.
• W2064742811 countsByYear W20647428112020 @default.
• W2064742811 countsByYear W20647428112021 @default.
• W2064742811 countsByYear W20647428112022 @default.
• W2064742811 crossrefType "journal-article" @default.
• W2064742811 hasAuthorship W2064742811A5009751300 @default.
• W2064742811 hasAuthorship W2064742811A5012384912 @default.
• W2064742811 hasAuthorship W2064742811A5014137251 @default.
• W2064742811 hasAuthorship W2064742811A5021206943 @default.
• W2064742811 hasAuthorship W2064742811A5024752023 @default.
• W2064742811 hasAuthorship W2064742811A5027093678 @default.
• W2064742811 hasAuthorship W2064742811A5027440713 @default.
• W2064742811 hasAuthorship W2064742811A5041319608 @default.
• W2064742811 hasAuthorship W2064742811A5059386443 @default.
• W2064742811 hasAuthorship W2064742811A5067134665 @default.
• W2064742811 hasAuthorship W2064742811A5072216201 @default.
• W2064742811 hasAuthorship W2064742811A5072944678 @default.
• W2064742811 hasAuthorship W2064742811A5077428594 @default.
• W2064742811 hasConcept C126322002 @default.
• W2064742811 hasConcept C142462285 @default.
• W2064742811 hasConcept C159047783 @default.
• W2064742811 hasConcept C168563851 @default.
• W2064742811 hasConcept C197934379 @default.
• W2064742811 hasConcept C203092338 @default.
• W2064742811 hasConcept C2777182164 @default.
• W2064742811 hasConcept C2778414717 @default.
• W2064742811 hasConcept C2779130552 @default.
• W2064742811 hasConcept C2779298103 @default.
• W2064742811 hasConcept C2779778239 @default.
• W2064742811 hasConcept C2781432083 @default.
• W2064742811 hasConcept C2993143319 @default.
• W2064742811 hasConcept C3013748606 @default.

• next